Anesthetic Considerations for Patients with Hereditary Neuropathy with Liability to Pressure Palsies: A Narrative Review.
Krzysztof LaudanskiOmar ElmadhounAmal MathewYul Kahn-PascualMitchell J KerfeldJames ChenDaniella C SisniegaFrancisco GomezPublished in: Healthcare (Basel, Switzerland) (2024)
Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant demyelinating neuropathy characterized by an increased susceptibility to peripheral nerve injury from trauma, compression, or shear forces. Patients with this condition are unique, necessitating distinct considerations for anesthesia and surgical teams. This review describes the etiology, prevalence, clinical presentation, and management of HNPP and presents contemporary evidence and recommendations for optimal care for HNPP patients in the perioperative period. While the incidence of HNPP is reported at 7-16:100,000, this figure may be an underestimation due to underdiagnosis, further complicating medicolegal issues. With the subtle nature of symptoms associated with HNPP, patients with this condition may remain unrecognized during the perioperative period, posing significant risks. Several aspects of caring for this population, including anesthetic choices, intraoperative positioning, and monitoring strategy, may deviate from standard practices. As such, a tailored approach to caring for this unique population, coupled with meticulous preoperative planning, is crucial and requires a multidisciplinary approach.
Keyphrases
- patients undergoing
- peripheral nerve
- end stage renal disease
- healthcare
- risk factors
- cardiac surgery
- ejection fraction
- newly diagnosed
- primary care
- chronic kidney disease
- quality improvement
- palliative care
- peritoneal dialysis
- risk assessment
- acute kidney injury
- clinical practice
- patient reported outcomes
- pain management
- affordable care act